Skip to main content
. 2024 Aug 2;10(15):e35591. doi: 10.1016/j.heliyon.2024.e35591

Fig. 7.

Fig. 7

(L–R). Docking of LNAPH (L), LO-VAN (R), and Favipiravir (as standard anti-COVID-19 drug) during the interaction with SARS-CoV-2 virus receptor protein (PDB ID: 6LU7).